Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Heart failure (HF) is a progressive disease characterized by variable durations of symptomatic stability often punctuated by episodes of worsening despite continued therapy. These periods of clinical worsening are increasingly recognized as a distinct phase in the history of HF, termed worsening HF (WHF). The definition of WHF continues to evolve from a historical focus solely on hospitalization to now include nonhospitalization events (eg, need for intravenous diuretic therapy in the emergency or outpatient setting). Most HF clinical trials to date have had HF hospitalization and death as primary endpoints, and only recently, some studies have included other WHF events regardless of location of care. This article reviews the evolution of the WHF definition, highlights the importance of considering the onset of WHF as an event that marks a new phase of HF, summarizes the latest clinical trials investigating novel therapies, and outlines unmet needs regarding identification and treatment of WHF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citationDapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Self-citation2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Sotagliflozin in patients with diabetes and recent worsening heart failure
Bhatt, D. L., Szarek, M., Steg, P. G., Cannon, C. P., Leiter, L. A., McGuire, D. K., Lewis, J. B., Riddle, M. C., Voors, A. A., Metra, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2030183 · Cited by 1,868
Self-citationAbraham, W. T., Adamson, P. B., Bourge, R. C., Aaron, M. F., Costanzo, M. R., Stevenson, L. W., Strickland, W., Neelagaru, S., Raval, N., Krueger, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60101-3 · Cited by 1,744
Vericiguat in patients with heart failure and reduced ejection fraction
Armstrong, P. W., Pieske, B., Anstrom, K. J., Ezekowitz, J., Hernandez, A. F., Butler, J., Lam, C. S. P., Ponikowski, P., Voors, A. A., Jia, G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915928 · Cited by 1,358
Self-citationMedical Therapy for Heart Failure With Reduced Ejection Fraction
Greene, S. J., Butler, J., Albert, N. M., DeVore, A. D., Sharma, P. P., Duffy, C. I., Hill, C. L., McCague, K., Mi, X., Patterson, J. H., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.070 · Cited by 1,314
Self-citationAngiotensin-neprilysin inhibition in acute decompensated heart failure
Velazquez, E. J., Morrow, D. A., DeVore, A. D., Duffy, C. I., Ambrosy, A. P., McCague, K., Rocha, R., & Braunwald, E. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812851 · Cited by 1,260
Voors, A. A., Angermann, C. E., Teerlink, J. R., Collins, S. P., Kosiborod, M., Biegus, J., Ferreira, J. P., Nassif, M. E., Psotka, M. A., Tromp, J., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01659-1 · Cited by 951
Self-citationPonikowski, P., Kirwan, B.-A., Anker, S. D., McDonagh, T., Dorobantu, M., Drozdz, J., Fabien, V., Filippatos, G., Göhring, U. M., Keren, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32339-4 · Cited by 795
Self-citationSolomon, S. D., Dobson, J., Pocock, S., Skali, H., McMurray, J. J. V., Granger, C. B., Yusuf, S., Swedberg, K., Young, J. B., Michelson, E. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.696906 · Cited by 681
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
Teerlink, J. R., Diaz, R., Felker, G. M., McMurray, J. J. V., Metra, M., Solomon, S. D., Adams, K. F., Anand, I., Arias-Mendoza, A., Biering-Sørensen, T., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2025797 · Cited by 656
Self-citationZile, M. R., Bennett, T. D., St. John Sutton, M., Cho, Y. K., Adamson, P. B., Aaron, M. F., Aranda, J. M., Abraham, W. T., Smart, F. W., Stevenson, L. W., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.783910 · Cited by 571
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial
Lindenfeld, J., Zile, M. R., Desai, A. S., Bhatt, K., Ducharme, A., Horstmanshof, D., Krim, S. R., Maisel, A., Mehra, M. R., Paul, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01754-2 · Cited by 432
The vulnerable phase after hospitalization for heart failure
Greene, S. J., Fonarow, G. C., Vaduganathan, M., Khan, S. S., Butler, J., & Gheorghiade, M. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.14 · Cited by 406
Self-citation2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
Hicks, K. A., Mahaffey, K. W., Mehran, R., Nissen, S. E., Wiviott, S. D., Dunn, B., Solomon, S. D., Marler, J. R., Teerlink, J. R., Farb, A., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.048 · Cited by 335
Pathophysiologic Targets in the Early Phase of Acute Heart Failure Syndromes
Gheorghiade, M., De Luca, L., Fonarow, G. C., Filippatos, G., Metra, M., & Francis, G. S. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.016 · Cited by 332
The Burden of Acute Heart Failure on U.S. Emergency Departments
Storrow, A. B., Jenkins, C. A., Self, W. H., Alexander, P. T., Barrett, T. W., Han, J. H., McNaughton, C. D., Heavrin, B. S., Gheorghiade, M., & Collins, S. P. (2014) · JACC: Heart Failure · doi:10.1016/j.jchf.2014.01.006 · Cited by 255
Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction
Butler, J., Yang, M., Manzi, M. A., Hess, G. P., Patel, M. J., Rhodes, T., & Givertz, M. M. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.049 · Cited by 245
Self-citationOkumura, N., Jhund, P. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Swedberg, K., Zile, M. R., Solomon, S. D., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.020729 · Cited by 186
Greene, S. J., Butler, J., Spertus, J. A., Hellkamp, A. S., Vaduganathan, M., DeVore, A. D., Albert, N. M., Duffy, C. I., Patterson, J. H., Thomas, L., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.0372 · Cited by 166
Self-citationOutpatient Worsening Heart Failure as a Target for Therapy: A Review
Greene, S. J., Mentz, R. J., & Felker, G. M. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2017.5250 · Cited by 145
Self-citationEfficacy of Sacubitril/Valsartan Relative to a Prior Decompensation
Solomon, S. D., Claggett, B. L., Packer, M., Desai, A., Zile, M. R., Swedberg, K. B., Rouleau, J. L., Shi, V. C., Lefkowitz, M. P., & McMurray, J. J. V. (2016) · JACC Heart Failure · doi:10.1016/j.jchf.2016.05.002 · Cited by 126
Felker, G. M., Solomon, S. D., Claggett, B. L., Díaz, R., McMurray, J. J. V., Metra, M., Anand, I. S., Crespo-Leiro, M. G., Dahlström, U., Gonçalvesová, E., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.4027 · Cited by 126
Abraham, W. T., Psotka, M. A., Fiuzat, M., Filippatos, G. S., Lindenfeld, J. M., Mehran, R., Ambardekar, A. V., Carson, P. E., Jacob, R., Januzzi, J. L., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2020.10.002 · Cited by 123
Docherty, K. F., Jhund, P. S., Anand, I., Bengtsson, O., Böhm, M., de Boer, R. A., DeMets, D. L., Desai, A. S., Drozdz, J., Howlett, J., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047480 · Cited by 95
Self-citationRisk Profiles in Heart Failure: Baseline, Residual, Worsening, and Advanced Heart Failure Risk
Greene, S. J., Fonarow, G. C., & Butler, J. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007132 · Cited by 90
Self-citationSilent Disease Progression in Clinically Stable Heart Failure
Sabbah, H. N. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.705 · Cited by 87
Recognizing Worsening Chronic Heart Failure as an Entity and an End Point in Clinical Trials
Butler, J., Braunwald, E., & Gheorghiade, M. (2014) · JAMA · doi:10.1001/jama.2014.6643 · Cited by 79
Self-citationSkali, H., Dwyer, E. M., Goldstein, R., Haigney, M., Krone, R., Kukin, M., Lichstein, E., McNitt, S., Moss, A. J., Pfeffer, M. A., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.71 · Cited by 76
Blecker, S., Ladapo, J. A., Doran, K. M., Goldfeld, K. S., & Katz, S. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.08.002 · Cited by 69
Analysis of Worsening Heart Failure Events in an Integrated Health Care System
Ambrosy, A. P., Parikh, R., Sung, S. H., Tan, T. C., Narayanan, A., Masson, R., Lam, P.-Q., Kheder, K., Iwahashi, A., Hardwick, A. B., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.04.045 · Cited by 68
Pocock, S., Ferreira, J. P., Gregson, J., Anker, S. D., Butler, J., Filippatos, G. S., Gollop, N. D., Iwata, T., Brueckmann, M., Januzzi, J. L., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab579 · Cited by 63
Self-citationOne‐Year Mortality After Intensification of Outpatient Diuretic Therapy
Madelaire, C., Gustafsson, F., Stevenson, L. W., Kristensen, S. L., Køber, L., Andersen, J., D’Souza, M., Biering‐Sørensen, T., Andersson, C., Torp-Pedersen, C. T., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.016010 · Cited by 59
Contextualizing Risk Among Patients With Heart Failure
Greene, S. J., Butler, J., & Fonarow, G. C. (2021) · JAMA · doi:10.1001/jama.2021.20739 · Cited by 50
Self-citationGreene, S. J., Butler, J., Fonarow, G. C., Subacius, H. P., Ambrosy, A. P., Vaduganathan, M., Triggiani, M., Solomon, S. D., Lewis, E. F., Maggioni, A. P., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1019 · Cited by 42
Self-citationKhan, M. S., Greene, S. J., Hellkamp, A. S., DeVore, A. D., Shen, X., Albert, N. M., Patterson, J. H., Spertus, J. A., Thomas, L. E., Williams, F. B., et al. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.008351 · Cited by 40
Self-citationCongestion and Diuretic Resistance in Acute or Worsening Heart Failure
Kristjánsdóttir, I., Thorvaldsen, T., & Lund, L. H. (2020) · Cardiac failure review · doi:10.15420/cfr.2019.18 · Cited by 36
Self-citationGreene, S. J., Felker, G. M., & Butler, J. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1341 · Cited by 16
Self-citationShah, A., Mentz, R. J., SUN, J.-L., RAO, V. N., Alhanti, B., Blumer, V. L., STARLING, R., Butler, J., & Greene, S. J. (2022) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.11.025 · Cited by 13
Self-citation
Cited by
Global Public Health Burden of Heart Failure: An Updated Review
Shahim, B., Kapelios, C. J., Savarese, G., & Lund, L. H. (2023) · Cardiac Failure Review · doi:10.15420/cfr.2023.05 · Cited by 627
Self-citationQian, L., Zhu, Y., Deng, C., Liang, Z., Chen, J., Chen, Y., Wang, X., Liu, Y., Tian, Y., & Yang, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01756-w · Cited by 338
Metadata
- Authors
- Greene, S. J., Bauersachs, J., Brugts, J. J., Ezekowitz, J. A., Lam, C. S. P., Lund, L. H., Ponikowski, P., Voors, A. A., Zannad, F., Zieroth, S., & Butler, J.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 81
- Issue
- 4
- Pages
- 413-424
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W4317797124
- Cited by
- 303
- References
- 40
- FWCI
- 53.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.